The therapeutic promises of Lianhuaqingke in the mice model of coronavirus pneumonia (HCoV-229E and SARS-CoV-2)
Research
[키워드] 16HBE cell
acute pneumonia
airway
alleviate
Anti-HCoVs therapy
Anti-viral
Antiviral effect
approved
BALB/c mice
caused
Cell
cells
ciliary
Coronavirus pneumonia
COVID-19
dose-dependent
Effect
ELISA
epithelial
expression
expression level
flow cytometry
H&E staining
hACE2
HCoV-229E
human coronaviruses (HCoVs)
identify
immune response
immunofluorescence staining
immunomodulation
immunomodulatory
in vitro
in vivo
indicated
inhibit
inhibited
inhibiting
Injury
Lianhuaqingke (LHQK)
lung
lung tissue
lung tissues
mice
morphological change
MUC5AC
Peripheral blood
Pneumonia
positive
pro-inflammatory cytokine
reduce
reduced
reducing
Replication
Result
SARS-CoV-2
staining
subset
Th cell
Th1
Th17
Th2
the SARS-CoV-2 virus
therapeutic
therapeutic effect
Therapies
TNFα
Transgenic mouse
treated
Treatment
Treg
Vero E6
viral replication
virus
virus titer
was measured
was used
weight loss
were measured
[DOI] 10.1186/s13020-021-00513-3 PMC 바로가기 [Article Type] Research
[DOI] 10.1186/s13020-021-00513-3 PMC 바로가기 [Article Type] Research